1938 – SHOULD THE CANCER REMEDY ACT OF 1938 BE REPEALED
Dr. Koch Publications
1912 – 1939
- 1912 – W. F KOCH Ph. D., M. D. ON THE OCCURRENCE OF METHYL GUANIDINE IN THE URINE OF PARATHYROIDECTOMIZED ANIMALS.
- 1913 – CHEMICAL CONSEQUENCES OF THE REMOVAL OF THE PARATHYROID GLANDS
- 1913 – THE PHYSIOLOGY OF THE PARATHYROID GLANDS
- 1913 – TOXIC BASES IN THE URINE OF PARATHYROIDECTOMIZED DOGS
- 1918 – TETANY AND THE PARATHYROID GLANDS
- 1919 – A NEW AND SUCCESSFUL DIAGNOSIS AND TREATMENT OF CANCER
- 1926 – CANCER ITS FUNCTION AND CURE, THE EVOLUTION OF THE IMMUNITY PROCESS
- 1926 – CANCER SUPPLEMENTARY POINTS
- 1926 – THE PREVENTION OF CANCER
- 1927 – BLOOD CHEMISTRY IN MALIGNANCY
- 1927 – THE KOCH CANCER TREATMENT AND ITS INVESTIGATIONS
- 1930 – ETIOLOGY AND TREATMENT OF CANCER AND TUBERCULOSIS
- 1931 – CASE REPORTS, BY WM. F. KOCH, PH.D., M.D., THE MICHIGAN JOURNAL OF OSTEOPATHIC MEDICINE AND SURGERY, VOL. 4. NO. 1
- 1936 – LETTER FROM KOCH LABORATORIES TO PHYSICIANS REGARDING GLYOXYLIDE
- 1937 – ETHYLENE KETO AND QUINONE GROUPS IN NATURAL IMMUNITY, ALLERGY, NEOPLASIA, AND INFECTION, THE JOURNAL OF THE AMERICAN COLLEGE OF PROCTOLOGY, VOL. X NO. 3
- 1938 – NATURAL IMMUNITY VIA AEROBIC GLYCOLYSIS
- 1938 – SHOULD THE CANCER REMEDY ACT OF 1938 BE REPEALED
- 1939 – CLINICAL DEMONSTRATION OF THE LAWS OF CHEMICAL STRUCTURE THAT DETERMINE IMMUNITY TO DISEASE, AND THEIR APPLICATION IN THE TREATMENT OF PATIENTS
- 1939 – NATIONAL IMMUNITY CLINICAL DEMONSTRATION OF THE LAWS OF CHEMICAL STRUCTURE THAT DETERMINE IMMUNITY TO DISEASE, AND THEIR APPLICATION IN THE TREATMENT OF PATIENTS
- 1939 – THE CHEMISTRY OF NATURAL IMMUNITY
- THE FUNCTION OF CANCER
1940 – 1949
- 1940 – THE BASIC CHEMISTRY OF OUR DIET
- 1941 – A BRIEF HISTORY OF THE DEVELOPMENT OF THE KOCH SYNTHETIC ANTITOXINS
- 1941 – AN EFFICIENT SINGLE DOSE TREATMENT FOR DIABETES, On A Full Carbohydrate Diet Without Insulin
- 1941 – CHEMISTRY’S VICTORY OVER DISEASE
- 1941 – PRINCIPLES OF THE KOCH THERAPY INTRODUCED IN 1918
- 1941 – RELATION OF FOCAL INFECTION TO CANCER AND ALLERGY IN CAUSATION AND RECOVERY
- 1941 – THE CURE OF DIABETES
- 1942 – LETTER TO C. A. ABBOTT, M.D. REGARDING FDA HARASSMENT OF PHYSICIANS
- 1942 – LTR KOCH TO PHYSICIAN REGARDING TREATMENT AND FEDERAL GOVERNMENT AND FBI INTERFERENCE
- KEY NOTE ADDRESS, BY DR. SAM SWAIN PRES. C.M.R.L. 2ND ANNUAL CONVENTION
- LTR KOCH TO PHYSICIAN, A FOLLOWUP REGARDING SEC. 503 FDA RULING ON LABELING AND KOCH
1950 – 1957
- 1958 – SURVIVAL FACTOR IN CANCER AND VIRAL INFECTION
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – APPENDIX
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 1: THE POSTULATE
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 10: RECENT PHARMACEUTICAL STRIDES
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 11: THE AZOMETHINE DOUBLE BOND
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 12: GENERAL ASPECTS OF THE REAGENTS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 13: CLEVAGE OF THE HOST-CELL PATHOGEN INTEGRATION
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 14: CATALYTIC DILUTIONS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 15: TERMINATION OF THE MALIGNANT PHASE RESTORATION OF THE FUNCTIONAL CARBONYL GROUP
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 16: THE TERMINATION OF THE MALIGNANT PHASE, THE CONSTITUTIONAL NATURE OF CANCER AND OF THE SURVIVAL FACTOR
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 17: VIRAL INFECTIONS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 18: TUBERCULOSIS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 19: PUS INFECTIONS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 2: VIRUS AND CANCER CELLS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 20: FIBROGENESIS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 21: THE PATHOGENIC MECHANISM IN CANCER AND CONNECTIVE TISSUE DISEASES
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 22: SEQUELAE TO INFECTION FAR ADVANCED ARTERIOSCLEROSIS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 23: ALLERGY PITYRIASIS RUBRA UNIVERSALIS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 24: PERCENTAGES AND CAUSES OF FAILURE
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 25: OBSERVATIONS IN ANIMAL DISEASES
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 26: DISEASES OF THE ARTICULATIONS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 27: CASE MANAGEMENT
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 28: PREVENTION OF CANCER, ALLERGY AND INFECTION
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 3: CANCER
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 4: PROOFS OF REVERSIBILITY
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 5: ANIMAL EXPERIMENTS
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 6: ENERGY PRODUCTION
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 7: CLINICAL PROOFS OF HIGH EFFICIENCY AND SSR OXIDATIONS TOXIC NODULAR GOITRE
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 8: ATROPHY, ANAPLASIA, AND NEOPLASIA
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – CHAPTER 9: THE ANTIBIOTIC PROBLEM
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – FULL BOOK PUBLICATION
- 1961 – THE SURVIVAL FACTOR IN NEOPLASTIC AND VIRAL DISEASES – INTRODUCTION
- 1963 – NEOPLASTIC AND VIRAL PARASITISM THEIR BASIC CHEMISTRY AND ITS CLINICAL REVERSAL
- 1963 – SCIENTISTS SEEK LEPROSY CURE IN TB VACCINE
- 1966 – THE KOCH CONCEPT (FOR THE SCIENTIFICALLY KNOWLEDGEABLE)
- 1967 – THE FUNCTIONAL CARBONYL GROUP IN PATHOGENESIS AND ITS REVERSAL
- DR. KOCH’S EXPLANATION OF THE FUNCTION OF HIS REAGENTS